Esophageal stricture surgery: Difference between revisions
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
Surgery is the mainstay of treatment for [disease or malignancy]. | Surgery is the mainstay of treatment for [disease or malignancy]. | ||
==Surgery== | ==Surgery== | ||
* Sent placement | |||
palliation of malignant esophageal strictures are stent placement (particularly in patients with an expected survival of 3 months or less) and brachytherapy (in patients with a life expectancy of more than 3 months) | |||
*Surgical intervention is not recommended for the management of [disease name]. | *Surgical intervention is not recommended for the management of [disease name]. | ||
OR | OR | ||
*Surgery is not the first-line treatment option for patients with | *Surgery is not the first-line treatment option for patients with esophageal stricture. Sent placement is usually reserved for patients with either: | ||
** | **Malignant esophageal strictures with a life expectancy less than three months<ref name="pmid18250638">{{cite journal |vauthors=Siersema PD |title=Treatment options for esophageal strictures |journal=Nat Clin Pract Gastroenterol Hepatol |volume=5 |issue=3 |pages=142–52 |year=2008 |pmid=18250638 |doi=10.1038/ncpgasthep1053 |url=}}</ref> | ||
**[Indication 2] | **[Indication 2] | ||
**[Indication 3] | **[Indication 3] | ||
Revision as of 20:33, 1 November 2017
|
Esophageal stricture Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
Esophageal stricture surgery On the Web |
|
American Roentgen Ray Society Images of Esophageal stricture surgery |
|
Risk calculators and risk factors for Esophageal stricture surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Surgery
- Sent placement
palliation of malignant esophageal strictures are stent placement (particularly in patients with an expected survival of 3 months or less) and brachytherapy (in patients with a life expectancy of more than 3 months)
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with esophageal stricture. Sent placement is usually reserved for patients with either:
- Malignant esophageal strictures with a life expectancy less than three months[1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].
Indications
References
- ↑ Siersema PD (2008). "Treatment options for esophageal strictures". Nat Clin Pract Gastroenterol Hepatol. 5 (3): 142–52. doi:10.1038/ncpgasthep1053. PMID 18250638.